View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Modality Solutions
11 November 2020

Modality Solutions to Hold Webinar on Transport Simulation Testing

Validating your cold chain to meet and exceed increasingly stringent regulatory expectations in today’s global market is a challenge.

With more than 35 international cold chain regulatory compliance guidance documents, global standards are becoming more comprehensive and increasingly complex. The testing strategies historically used to test packing only (i.e., ASTM, ISTA) is no longer considered a comprehensive test to confirm drug product integrity for regulators around the globe.

Key learning objectives

  • Integrate transport simulation testing for environmental hazards into your filing strategy
  • Understand why ASTM and ISTA package testing is not acceptable for drug product testing
  • Learn the challenges of “real world” testing and why it is less reliable than transport simulation
  • Discuss the challenges to “real world” shipment testing in a post-COVID-19 transportation network
  • Join industry experts Gary Hutchinson and Dan Littlefield from Modality Solutions in this engaging and informative webinar on how to successfully integrate transport simulation into your biopharmaceutical filing.

Modality Solutions has access to the latest regulatory agency requirements for emerging new therapies and will share how to successfully validate your biopharmaceutical cold chain with transport simulation. Register today for the webinar on a better approach to “real world” shipping tests using transport simulation technology.

There will also be a live Q&A at the conclusion of the presentation.

The webinar will take place on 2 December 2020 at 6PM London / 1PM New York / 10AM San Francisco.

Can’t make the scheduled time? Register and we will send you the recording of the complete webinar.

Competing priorities, changing expectations, cost pressures, sustainability initiatives, emerging markets - these are some of the challenges facing cold chain management professionals every day. Solutions...
Regenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell...
Immunomedics ( is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer.
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company headquartered in New York City that specialises in discovering, developing and delivering innovative medicines for patients with...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology